Wednesday, 7 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Vimta Labs Ltd

NSE: VIMTALABS · BSE: 524394 · Healthcare · 28 announcements

Share price: ₹570.05
Market cap: ₹2,548 Cr
Revenue (annual): ₹407.3 Cr
Net profit (annual): ₹77.51 Cr
P/E (TTM): 32.0×Sector 53.1×
Promoter holding: 35.67%-0.18% QoQ
FII holding: 4.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Employee Stock Options 3 Results Update 2 Other Announcement 2 Management Change 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Price Movement Clarification 1 Debt & Borrowing 1 Credit Rating 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

20 Jul 2026 13:38 IST NSE

Financial Results

Vimta Labs Q1 FY27 Results: Net Profit ₹21 Cr, Up 11.1% YoY

Vimta Labs Ltd reported revenue from operations of ₹109.1 Cr (+11.8% YoY) and net profit of ₹21 Cr (+11.1% YoY) for Q1 FY27.

Key figure: Net profit ₹21 Cr · +11.1% YoY

Open full results → Read the filing ↗

6 May 2026 15:53 IST BSE

Financial Results

Vimta Labs Q4 FY26 Results: Net Profit ₹21.1 Cr, Up 15.3% YoY

Vimta Labs Ltd reported revenue from operations of ₹109.2 Cr (+15.7% YoY) and net profit of ₹21.1 Cr (+15.3% YoY) for Q4 FY26.

Key figure: Net profit ₹21.1 Cr · +15.3% YoY

Open full results → Read the filing ↗

6 May 2026 15:53 IST BSE

Financial Results

Vimta Labs Financial Results

Vimta Labs Limited reported its audited financial results for the year ended March 31, 2026, with total income reaching ₹416.28 Crore. The board recommended a dividend of ₹2 per share and approved incorporating a wholly owned subsidiary in the USA. Additionally, Dr. S. P. Vasireddi was reappointed as Executive Chairman for a five-year term.

Read the filing ↗